# A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis

> **NCT07184645** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 198 (estimated)

## Conditions studied

- Atopic Dermatitis (AD)

## Interventions

- **DRUG:** OPA-15406
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT07184645
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 198 (ESTIMATED)
- **Last updated:** 2025-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07184645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07184645, "A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07184645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*